FDA Calls On Drugmaker To Pull A Powerful Opioid Off The Market
(By Rob Stein for NPR) The Food and Drug Administration requested Thursday that the drugmaker Endo Pharmaceuticals stop selling Opana
Read More
Part D/Prescription Drugs
Former Pharma Reps’ New Mission: To School Docs On High Drug Costs
(By Jay Hancock for Kaiser Health News) As a drug salesman, Mike Courtney worked hard to make health care expensive.
Read MoreSenate to Hold Hearing on Drug Pricing
The Health, Education, Labor and Pensions (HELP) committee will hold a hearing on June 13, 2017, on drug pricing, questioning
Read MoreMedicare Part D and Its Impact on the Elderly
With the implementation of Medicare Part D, seniors and those under age 65 with permanent disabilities, have experienced an increased
Read MorePfizer makes 2nd price hike this year for nearly 100 drugs: 4 things to know
(By Mackenzie Bean for Becker’s Hospital Review) Pfizer on June 1 increased the U.S. list prices for nearly 100 drugs
Read MoreAnticipating Drug Pricing Plans from the Trump Administration
Two of the top pharmaceutical executives’ Jose Jimenez, CEO Novartis and Brent Saunders, CEO of AllerganPlc, anticipate proposals from the
Read MoreCoaching Overdose Survivors to Avoid the Next One
(By Christine Vestal for Stateline) published June 2, 2017 NEW YORK — Five months into his job at a 24-hour
Read MoreHHS makes $70M in grants available to address opioid epidemic
(By Brian Zimmerman for Becker’s Hospital Review) HHS Secretary Tom Price, MD, on Wednesday said the agency will offer more
Read MoreKratom with a side of cheesesteak: A sub shop’s vending machine draws customers desperate to kick opioids
(By Eric Boodman for STAT) TUCSON, Ariz. — Besides the psychoactive properties of eggplant parm and mid-century nostalgia, there isn’t
Read MoreA Drug Quintupled in Price. Now, Drug Industry Players Are Feuding Over the Windfall.
(By Charles Ornstein, ProPublica, and Katie Thomas, The New York Times, May 31, 2017) A company that manages prescription drug
Read More